Physician profile
Stuart J Beldner
NPI 1720159114
$15,488.71
in general payments reported to CMS, 2019-2025
15 companies · $1,878 in 2025
The $1,878 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $843 · 2021: $2,466 · 2022: $2,466 · 2023: $4,070 · 2024: $2,340 · 2025: $1,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,990 · Travel and Lodging: $3,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,989.66 |
| Travel and Lodging | $3,297.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,574.56 | 2019-2025 | Emblem Mri S-Icd, Watchman Access System, Watchman Flx |
| Medtronic, INC. | $4,424.47 | 2021-2025 | Selectsecure, Micra, Attain Command + Surevalve |
| Biosense Webster, INC. | $2,317.37 | 2020-2025 | Thermocool Sf, Carto 3, Qdot Micro Catheter |
| Abbott Laboratories | $1,418.03 | 2021-2025 | Amplatzer Amulet, Jot Dx, Perclose Prostyle |
| Medtronic Vascular, INC. | $394.96 | 2019-2020 | |
| Edwards Lifesciences Corporation | $314.56 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $287.33 | 2020-2024 | Optimizer |
| Philips North America LLC | $177.36 | 2023-2024 | (Ck7) Extended Holter |
| Biotronik INC. | $155.81 | 2021 | |
| Atricure, INC. | $143.62 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $111.87 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Cordis US Corp. | $86.30 | 2025 | Mynx Control Venous |
| Angiodynamics, INC. | $34.57 | 2024 | Alphavac |
| Alnylam Pharmaceuticals INC. | $24.12 | 2024 | Amvuttra |
| Janssen Pharmaceuticals, INC | $23.78 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Beldner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.